News
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI ® (ublituximab-xiiy) in patients with relapsing ...
Blood agency is encouraging Canadians to step up now in a show of unity with other Canadians to support the national supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback